Prognostic Value of Exhaled Isoprene Levels for Morbidity and Functional Outcome in Cardiosurgical Patients

Last updated: December 16, 2023
Sponsor: University of Rostock
Overall Status: Active - Recruiting

Phase

N/A

Condition

Sarcopenia

Polymyositis (Inflammatory Muscle Disease)

Treatment

Physical performance testing

Blood-based biomarker analysis

Muscle ultrasound

Clinical Study ID

NCT06175429
PREDICT
  • Ages > 65
  • All Genders

Study Summary

The perioperative preservation of functionality and quality of life plays an increasingly important role in older physically limited and frail patients undergoing cardiac surgery. Hereby, impairments of the skeletal muscle system integrity often contributes to a reduced physical performance. Early identification of these high-risk patients could help to initiate appropriate preventive and therapeutic measures. Volatile organic compounds (VOC) represent a non-invasive and real-time measurable approach for recording physiological and pathophysiological processes. Isoprene (2-methyl-1,3-butadiene) is one of the most abundantly exhaled VOCs and has recently been shown to originate from skeletal muscle metabolism. However, the prognostic value of isoprene as a volatile biomarker for skeletal muscle integrity, physical performance and functional outcome in patients undergoing cardiac surgery has not been evaluated before.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age >= 65 years
  • planned cardiac surgery
  • operation duration >60 min

Exclusion

Exclusion Criteria:

  • refusal of study participation
  • emergency / urgent surgery
  • acute myocardial infarction
  • acute or chronic infection
  • Pre-existing illness with permanent restriction of mobility
  • Pre-existing neuromuscular disease
  • current malignant disease
  • terminal renal insufficiency
  • severe liver cirrhosis
  • severe obstructive pulmonary disease

Study Design

Total Participants: 66
Treatment Group(s): 4
Primary Treatment: Physical performance testing
Phase:
Study Start date:
November 27, 2023
Estimated Completion Date:
December 31, 2025

Study Description

This is a single center prospective observational study evaluating exhaled isoprene as a perioperative volatile biomarker of skeletal muscle integrity, physical performance and functional outcome in cardiosurgical patients. All study participants will be assessed by comprehensive clinical examinations, laboratory testing, breath analysis and skeletal muscle ultrasound before, during as well as five and thirty days after surgery. Clinical assessments will be performed using established clinical scores and scales (e.g. the Short Physical Performance Battery and the Fried Frailty Index). Laboratory testing comprises a broad panel of blood-based biomarkers of skeletal muscle integrity and metabolism.

The investigators hypothesize that:

  • perioperative exhaled isoprene levels correlate with postoperative measures of physical performance, functional outcome and morbidity

  • perioperative exhaled isoprene levels differ between patients with and without physical frailty

  • perioperative exhaled isoprene levels correlate with sonographic and laboratory parameters of skeletal muscle integrity

Connect with a study center

  • Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Rostock University Medical Center

    Rostock, Mecklenburg-Vorpommern 18057
    Germany

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.